期刊文献+

卵巢浆液性癌的研究进展 被引量:3

下载PDF
导出
摘要 卵巢浆液性癌以前多认为是起源于卵巢表面上皮或上皮内陷形成的皮质包涵体。近年来,随着分子生物学与分子遗传学技术的不断发展,研究显示卵巢浆液性癌存在二元发病模式,分别为低级别与高级别浆液性癌。低级别癌由良性、交界性肿瘤发展而来,多伴有KRAS、BRAF或ERBB2突变;高级别卵巢癌大多来源于输卵管上皮,常伴有TP53突变。本文现从卵巢浆液性癌的组织学分级、免疫表型及组织起源方面作一综述。
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第10期1140-1142,1145,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 南京军区面上课题(07M084)
  • 相关文献

参考文献25

  • 1Malpica A, Deavers M T, Lu K, et al. Grading ovarian serouscarcinoma using a two-tier system[ J]. Am J Surg Pathol,2004,28(4) :496 -504.
  • 2Malpica A, Deavers M T, Tomos C, et al. Interobserver and in-traobserver variability of a two-tier system for grading ovarian se-rous carcinoma[ J]. Am J Surg Pathol,2007,31 (8) :1168 -74.
  • 3Seidman J D, Horkayne-Szakaly I,Cosin J A, et al. Testing oftwo binary grading systems for FIGO stage M serous carcinoma ofthe ovary and peritoneum[ J]. Gynecol Oncol, 2006,103(2) :703-8.
  • 4Vang R, Shih Ie M, Kurman R J. Ovarian low-grade and high-grade serous carcinoma : pathogenesis, clinicopathologic and mo-lecular biologic features,and diagnostic problems [ J]. Adv AnatPathol, 2009,16(5):267 -82.
  • 5Ayhan A, kurman R J, Yemelyanova A, et al. Defining the cutpoint between low-grade and high-grade ovarian serous carcino-mas; a clinicopathologic and molecular genetic analysis[ J]. Am JSurg Pathol,2009,33(8); 1220 - 4.
  • 6沈旭霞,喻林,毕蕊,杨文涛.卵巢低、高级别浆液性癌的临床病理分析及Pax2、p53和Ki-67表达的意义[J].中华病理学杂志,2011,40(8):511-516. 被引量:18
  • 7Przybycin C G, Kurman R J, Ronnett B M, ei al. Are all pelvic(non uterine) serous carcinomas of tubal origin [ J]? Am J SurgPathol, 2010,34(10):1407-16.
  • 8刘冲,石群立.卵巢癌免疫标记物研究进展[J].医学研究生学报,2010,23(9):985-988. 被引量:14
  • 9Dubeau L. The cell of origin of ovarian epithelial tumors[ J]. Lan-cet Oncol, 2008,9(12) ;1191 -7.
  • 10Kurman R J, Shih Ie M. Pathogenesis of ovarian cancer: lessonsfrom morphology and molecular biology and their clinical implica-tions[J]. Int J Gynecol Pathol, 2008,27(2) :151 -60.

二级参考文献98

  • 1刘琦,吴波,姜少军,孟奎,石群立,施正良.全反式维甲酸对卵巢上皮性癌荷瘤鼠干预后肿瘤细胞的超微结构变化[J].电子显微学报,2005,24(6):584-589. 被引量:11
  • 2刘锴颉,谭文华,胡雪芬.Ki-67和CD44v5在卵巢癌中的表达和临床意义[J].中国优生与遗传杂志,2007,15(4):36-37. 被引量:2
  • 3Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation [ J]. Nature ,2008,454(7203 ) :436 - 444.
  • 4Jemal A, Siegel R, Ward E, et al. Cancer statistics [ J ]. CA Cancer J Clin, 2008,58 ( 2 ) : 71 - 96.
  • 5Sueblinvong T, Carney ME. Current understanding of risk factors for ovarian cancer [ J]. Curr Treat Options Oneol, 2009,10(1-2) :67 - 81.
  • 6Leeper K, Garcia R, Swisher E, et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women [ J]. Gynecol Oncol,2002,87 ( 1 ) :52 - 56.
  • 7Medeiros F, Muto MG,Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome [J]. Am J Surg Pathol, 2006,30 (2) : 230 - 236.
  • 8Sogaard M, Kjaer SK, Gayther S. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention [ J]. Acta Obstet Gynecol Scand, 2006, 85 ( 1 ) :93 - 105.
  • 9Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers [ J]. Gynecol Oncol,2006, 100(1) :58 -64.
  • 10Carcangiu ML, Peissel B, Pasini B, et al. Incidental carcinomas in prophylactic specimens in BIICA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions, report of 6 cases and review of the literature [J]. Am J Surg Pathol,2006,30 (10) : 1222 - 1230.

共引文献34

同被引文献19

  • 1Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2008[J].CA Cancer J Clin, 2008, 58(2): 71-96.
  • 2Lee Y, Miron A, Drapkin R, et al.A candidate precursor to serous carcinoma that originates in the distal fallopian tube[J].J Pathol, 2007, 211(1): 26-35.
  • 3Kurman R J, Shihie M.Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications[J].Int J Chinese and Foreign Medical Research Vol.11, No.15 May, 2013.GyneeolPathol, 2008, 27(2): 151-160.
  • 4Roth M H, Kindelberger D, Crum C P.Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin[J]. Am J Surg Pathol, 2009, 33(3): 376-383.
  • 5陈淑琴,姚书忠,牛刚,陈玉清,谢洪哲,徐成康.216例腹腔镜下全子宫切除术的临床观察[J].中国内镜杂志,2007,13(12):1271-1275. 被引量:41
  • 6Diet1 J, Wischhusen J, Hausler SF. The post-reproductive Fallo- pian tube : better removed? [ J ]. Hum Reprod, 2011,26 ( 11 ) : 2918 - 2924.
  • 7Salvador S, Gilks B, Ktibel M, et al. The fallopian tube: primary site of moatpelvic high-grade serous carcinomas [J]. Int J Gynecol Cancer, 2009,19 ( 1 ) : 58-64.
  • 8Strandell A, Waldenstrtim U, Nilsson L, et al. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates [J]. Hum Reprod, 1994,9(5 ) : 861-863.
  • 9金影,靳家玉.残留卵巢综合征20例诊治分析[J].中国误诊学杂志,2009,9(9):2214-2215. 被引量:4
  • 10王海燕,蔡春华.B超监测子宫输卵管通液造影诊断不孕症238例分析[J].西南国防医药,2010,20(5):525-526. 被引量:10

引证文献3

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部